Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of November 2024. The filing, dated November 12, 2024, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement containing quantitative data.
Material Changes
The filing text does not provide details on material changes versus prior periods. The content is limited to the notification of the press release issuance.
Guidance, Outlook, and Risks
Specific guidance, management commentary, risks, contingencies, or unusual items are not detailed within the body of this Form 6-K. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text.
Key Facts for Investor Verification
- Verify the content of the press release dated November 12, 2024, attached as Exhibit 99.1, as this filing contains no substantive operational or financial data.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.